Serum magnesium level and cardiac valve calcification in hemodialysis patients

Shihming Tsai1, Yuehong Li2, Xianglan Wu1

  • 1Department of Nephrology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, 168 Litang Road, Changping District, Beijing, 102218, China.

PubMed

Insights

Low magnesium levels are linked to cardiac valve calcification in hemodialysis patients. This finding highlights the importance of monitoring magnesium and calcium levels in this population.

Area of Science:

  • Nephrology
  • Cardiology
  • Biochemistry

Background:

  • Cardiac valve calcification is a significant complication in patients undergoing maintenance hemodialysis.
  • It is closely associated with increased cardiovascular disease risk.

Purpose of the Study:

  • To investigate the relationship between serum magnesium levels and the prevalence of cardiac valve calcification in hemodialysis patients.
  • To identify clinical factors associated with cardiac valve calcification in this cohort.

Main Methods:

  • A cross-sectional study involving 105 maintenance hemodialysis patients.
  • Echocardiography was used to assess cardiac valve calcification.
  • Clinical data, including electrolytes and parathyroid hormone, were analyzed.

Main Results:

  • Over 64% of patients exhibited cardiac valve calcification.
  • Cardiac valve calcification was associated with older age, diabetes mellitus, and coronary artery calcification.
  • Lower levels of serum magnesium, serum calcium, and parathyroid hormone were observed in patients with valve calcification.

Conclusions:

  • Cardiac valve calcification in hemodialysis patients is associated with age, serum calcium, and notably, lower serum magnesium levels.
  • These findings underscore the clinical importance of monitoring magnesium and calcium levels in hemodialysis patients to potentially mitigate cardiac valve calcification.
Abstract

Related Concept Videos